In addition, our study indicates that hemopexin, a heme scavenger, and glycyrrhizin, a HMGB1 inhibitor, could alleviate SIRS after RFA of hepatic hemangioma. The gene discussed is HMGB1; the disease is systemic inflammatory response syndrome.